Pharma Journalist -

Discover the future of clinical development at Adaptive Designs in Clinical Trials Conference 2019 SMi Group are proud to announce the 11th annual Adaptive Designs in Clinical Trials…
Read More...

Eton Pharmaceuticals, Inc. announced that it has entered into an exclusive licensing and supply agreement with Sintetica SA, a Swiss-based pharmaceutical company, to obtain U.S.…
Read More...

WuXi Biologics and Amicus Therapeutics announced that the companies have entered into an exclusive commercial manufacturing partnership for Amicus' Pompe biologic ATB200. Per the…
Read More...

3SBio Inc. and Verseau Therapeutics, Inc. announced a partnership agreement focused on the development and commercialization of novel monoclonal antibodies in the field of…
Read More...

Moberg Pharma AB has signed an exclusive license agreement with Bayer for commercialization of MOB-015 in Europe. Under the agreement, Moberg Pharma is eligible to receive up to EUR 50…
Read More...

Latest Developments in Combating Antifungal Resistance to be discussed by Industry Leaders at Superbugs & Superdrugs Conference in London SMi Reports: Superbugs & Superdrugs…
Read More...

The Pre-Filled Syringes East Coast Conference – April 8-9 , Sheraton Boston Hotel, Boston, MA, USA – is an essential platform to discuss the latest issues, engage and network with the…
Read More...

GlaxoSmithKline plc and Merck KGaA, Darmstadt, Germany announced that they have entered into a global strategic alliance to jointly develop and commercialise M7824 (bintrafusp alfa).…
Read More...

Xencor announced it has entered into a research and license agreement with Genentech, a member of the Roche Group, to develop and commercialize novel IL-15 cytokine therapeutics,…
Read More...

Evotec AG and Galapagos NV announced a global collaboration focused on a novel target for fibrosis and other indications. The collaboration concerns a small molecule programme,…
Read More...